Demcizumab (Anti-DLL4)
Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2520 |
| Sku # | A2520-1mg*5 |
| Pricing | 1mg*5, $1390.00 |